Release Date: 25/08/21 09:11 Summary: ABR US Listing to Benefit from US Boron Supply Constraints Price Sensitive: Yes Download Document 151.56KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%